Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT-J trial.

Changes were less consistent and sometimes failed to reach statistical significance in the ≥65 years subgroup for blood pressure and lipid improvements (Figure S2 ; Table S2 ), whereas the mean percentage reductions in FSG in the ≥65 years subgroup were similar to those in the other subgroups (Figure S3 ). 3.5.

also in 6,035 other papers